InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+36.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hill Matthew C, Chief Financial Officer. Insider active across 2 companies, notably PDS Biotechnology Corp. Cumulatively, 4 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €37k. History available since 13 December 2021. The latest transaction was filed on 13 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hill Matthew C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
6,000 shares@ US$1.1336.8% of flowCommon StockSEC:0001493152-25-008863:0
Canonical exit: 11 Nov 2024 (T+90)
5,336 shares@ US$1.1332.8% of flowCommon StockSEC:0001493152-24-031725:0
Canonical exit: 11 Nov 2024 (T+90)
2,500 shares@ US$2.1930.4% of flowCommon StockSEC:0001493152-23-044805:0
Canonical exit: 11 Mar 2024 (T+90)
2,500 shares@ US$9.00100.0% of flowCommon StockSEC:0001140361-21-041473:0
Canonical exit: 13 Mar 2022 (T+90)
4 of 4 declarations
About Hill Matthew C
Matthew C. Hill is the Chief Financial Officer at PDS Biotechnology Corp. He oversees financial management and budgeting strategies for the company. His expertise is essential for ensuring the financial health and compliance of the firm.
